The Innovation Agency has won a prestigious award for its work with North West Coast businesses in the health...Read more
£86 million funding announced for new medicine and technology
The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs.
The package will allow small and medium sized enterprises (SMEs) to develop and test new technologies in the NHS. This could include innovations such as digital technologies to help patients manage their conditions from home instead of a hospital, or to develop new medicines.
Access to this funding will also speed up the time it takes to get new technologies from the lab to patients in the NHS.
The announcement is the first step in taking forward the Accelerated Access Review (AAR) – an independently chaired review, which made recommendations to government on speeding up patient access to new technologies.
Technologies that have previously received support are already bringing benefits to patients. For example, MyCOPD is an online system that helps people with chronic obstructive pulmonary disease (COPD) better manage their condition. It has helped over 32,000 patients by helping them improve their breathing, manage flare-ups and track medicine use. This reduces reliance on GP and hospital appointments.
Health Minister Lord O’Shaughnessy said:
“The government’s ambition is that NHS patients get world-leading, life-changing treatments as fast as possible.
“That can’t happen unless we support medical innovation and tear down the barriers – like speed to market and access to funding – that can get in the way, especially for SMEs.
“Our investment in innovation shows how much we value the UK life sciences sector.”
The funding is split into 4 packages. These include:
•£39 million of funding to the Academic Health Science Networks (ASHNs), enabling them to assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients according to the local need
•£35 million Digital Health Technology Catalyst for innovators – this will match-fund the development of digital technologies for use by patients and the NHS
•up to £6 million over the next 3 years to help SMEs with innovative medicines and devices get the evidence they need by testing in the real world, building on existing opportunities such as the Early Access to Medicine Scheme (EAMS)
•£6 million Pathway Transformation Fund, which will help NHS organisations integrate new technologies into everyday practices – this will help overcome more practical obstacles such as training staff on how to use new equipment
To find out more, please click here
A new collaboration launched at the end of November by DigitalHealth.London (DH.L) and RYSE Asset Management LLP to support...Read more
Health Innovation Manchester’s STEP INto Healthcare programme received a commendation in Bionow’s 2017 Business Services Award, which aims to...Read more
A partnership between a company and an NHS university hospital has been awarded the prestigious Bionow Healthcare Project of...Read more
Health Education England, in association with NHS England and NHS Digital, are working together to improve the digital capabilities...Read more
Japanese pharmaceutical and health care specialists, Asahi Kasei recently launched an open innovation competition to identify new drugs and...Read more
Date: Thursday 8th February 2018, 1000-1600 Location: STFC Sci-Tech Daresbury Innovate UK and it’s partners the Science and Technology...Read more
Subscribe for Updates
Register to receive newsletters and information about new programmes and events.